No Data
Returns On Capital At Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Have Stalled
Cautious Investors Not Rewarding Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.'s (SHSE:605016) Performance Completely
Bailong Chuangyuan: Report for the third quarter of 2024
2024 Third Quarter Report
Announcement on major operating data for the third quarter of 2024
Baolong Innovation Park (605016.SH) net income for the first three quarters increased by 29.19%, planning to distribute a dividend of 0.2 yuan.
On October 30th, Baolong Innovation Park (605016.SH) released the third quarter report for 2024, with the company achieving revenue of 0.82 billion yuan in the first three quarters, a year-on-year increase of 25.48%; net income attributable to shareholders of 0.183 billion yuan, a year-on-year increase of 29.19%. In the third quarter alone, revenue reached 0.289 billion yuan, a year-on-year increase of 19.92%; net income attributable to shareholders was 63.0293 million yuan, a year-on-year increase of 25.46%. The company plans to distribute a cash dividend of 0.2 yuan (tax included) per 10 shares to all shareholders.
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (SHSE:605016) Not Flying Under The Radar
